Volume 8, 2021
Volume 8, 2021 is now on PubMed »
 |
About the CoverThe cover for Oncoscience Volume 8, 2021 features Figure 5, "Hypothetical scenarios of adding anti-aging treatments to current medical care," from https://doi.org/10.18632/oncoscience.547 |
Research Perspectives
Monitoring vascular normalization: new opportunities for mitochondrial inhibitors in breast cancer
https://doi.org/10.18632/oncoscience.523
Silvana Mouron, Maria J. Bueno, Manuel Muñoz, Miguel Quintela-Fino
p 1-13
Research Papers
The helix-loop-helix transcriptional regulator Id4 is required for terminal differentiation of luminal epithelial cells in the prostate
https://doi.org/10.18632/oncoscience.524
Dhanushka Hewa Bostanthirige, Shravan K. Komaragiri, Jugal B. Joshi, Majid Alzahrani, Isha Saini, Sanjay Jain, Nathan J. Bowen, Matthew C. Havrda, Jaideep Chaudhary
p 14-30
Abstract | PDF | Full Text | How to Cite
Research Perspectives
Upper gastrointestinal cancers in Lynch syndrome: the time for surveillance is now
https://doi.org/10.18632/oncoscience.525
Shria Kumar, Bryson W. Katona
p 31-33
Research Perspectives
AKT as a therapeutic target for autophagy induction and cancer therapy
https://doi.org/10.18632/oncoscience.526
Qi Wu, Yi Tu, Guido Kroemer, Oliver Kepp
p 34-36
Research Perspectives
Causation of increased prostate cancer in young men
https://doi.org/10.18632/oncoscience.527
Archie Bleyer, Filippo Spreafico, Ronald Barr
p 37-39
Research Perspectives
Balancing efficacy and quality of life measurements among metastatic renal cell carcinoma (RCC) studies
https://doi.org/10.18632/oncoscience.528
Jeanny B. Aragon-Ching
p 40-45
Corrections
Correction: Lactate dehydrogenase A inhibition by small molecular entities: steps in the right direction
https://doi.org/10.18632/oncoscience.529
Btissame El Hassouni, Marika Franczak, Mjriam Capula, Christian M. Vonk, Valentina M. Gomez, Ryszard T. Smolenski, Carlotta Granchi, Godefridus J. Peters, Filippo Minutolo, Elisa Giovannetti
p 46-46
Research Perspectives
Importance of amino acids in brain parenchyma invasion by cancer cells
https://doi.org/10.18632/oncoscience.530
Alessio Paone, Amani Bouzidi, Serena Rinaldo, Giorgio Giardina, Francesca Cutruzzolà
p 47-49
Research Perspectives
Alternative splicing of CERS2 promotes cell proliferation and migration in luminal B subtype breast cancer cells
https://doi.org/10.18632/oncoscience.531
Trishna Pani, Kajal Rajput, Animesh Kar, Ujjaini Dasgupta
p 50-52
Research Perspectives
A novel RNA- based approach to counteract EMT
https://doi.org/10.18632/oncoscience.532
Sabrina Garbo, Marco Tripodi, Cecilia Battistelli
p 53-54
Research Perspectives
A “two-hit” (chemo)therapy to improve checkpoint inhibition in cancer
https://doi.org/10.18632/oncoscience.533
Paolo Falvo, Stefania Orecchioni, Alessro Raveane, Giulia Mitola, Francesco Bertolini
p 55-57
Research Perspectives
p53 activation vs. stabilization: an acetylation tale from the C-terminal tail
https://doi.org/10.18632/oncoscience.534
Ning Kon, Wei Gu
p 58-60
Research Papers
Constitutive activation of MEK5 promotes a mesenchymal and migratory cell phenotype in triple negative breast cancer
https://doi.org/10.18632/oncoscience.535
Margarite D. Matossian, Van T. Hoang, Hope E. Burks, Jacqueline La, Steven Elliott, Courtney Brock, Douglas B. Rusch, Aaron Buechlein, Kenneth P. Nephew, Akshita Bhatt, Jane E. Cavanaugh, Patrick T. Flaherty, Bridgette M. Collins-Burow, Matthew E. Burow
p 61-71
Abstract | PDF | Full Text | Supplementary Material | How to Cite
Research Perspectives
Radiomic-based diagnostics in oncology: challenges toward clinical practice
https://doi.org/10.18632/oncoscience.536
Emanuele Barabino, Giovanni Rossi, Alessandro Fedeli, Giuseppe Cittadini, Carlo Genova
p 72-73
Research Perspectives
SCIRT lncRNA slows the formation of tumour initiating cells in breast cancer
https://doi.org/10.18632/oncoscience.537
Alex de Giorgio, Lero Castellano
p 74-75
Research Perspectives
A precision approach to breast cancer treatment based on cell lineage-specific vulnerabilities
https://doi.org/10.18632/oncoscience.538
Jay S. Desgrosellier
p 76-79
Research Perspectives
Re-enforcing the strategy of targeting MEK/ERK signaling to overcome acquired resistance to third generation EGFR inhibitors
https://doi.org/10.18632/oncoscience.539
Wen Zhao, Shi-Yong Sun
p 80-81
Research Perspectives
Advances in culture methods for acute myeloid leukemia research
https://doi.org/10.18632/oncoscience.540
Krishnapriya Syama, Eman M. Hassan, Shan Zou
p 82-90
Research Perspectives
Determining the utility of a screening program to reduce the incidence of HPV driven oropharyngeal cancer
https://doi.org/10.18632/oncoscience.541
Sarju Vasani, Ian Frazer, Chamindie Punyadeera
p 91-93
Research Perspectives
New insight into the role of MDMX in MDM2-mediated p53 degradation and anti-cancer drug development
https://doi.org/10.18632/oncoscience.542
Jing Yang, Yanping Zhang
p 94-96
Research Perspectives
Tune the channel: TRPM8 targeting in prostate cancer
https://doi.org/10.18632/oncoscience.543
Alessandro Alaimo, Dario De Felice, Sacha Genovesi, Marco Lorenzoni, Andrea Lunardi
p 97-100
Editorials
Taking action early to manage emergence of acquired resistance to osimertinib or other third generation EGFR inhibitors
https://doi.org/10.18632/oncoscience.544
Guangzhi Ma, Shi-Yong Sun
p 101-102
Editorial Perspective
The hyperfunction theory of aging: three common misconceptions
https://doi.org/10.18632/oncoscience.545
Mikhail V. Blagosklonny
p 103-107
Corrections
Correction: Targeting focal adhesion kinase overcomes erlotinib resistance in smoke induced lung cancer by altering phosphorylation of epidermal growth factor receptor
https://doi.org/10.18632/oncoscience.546
Hitendra S. Solanki, Remya Raja, Alex Zhavoronkov, Ivan V. Ozerov, Artem V. Artemov, Jayshree Advani, Aneesha Radhakrishnan, Niraj Babu, Vinuth N. Puttamallesh, Nazia Syed, Vishalakshi Nanjappa, Tejaswini Subbannayya, Nandini A. Sahasrabuddhe, Arun H. Patil, T.S. Keshava Prasad, Daria Gaykalova, Xiaofei Chang, Rachana Sathyendran, Premendu Prakash Mathur, Annapoorni Rangarajan, David Sidransky, Akhilesh Pandey, Evgeny Izumchenko, Harsha Gowda, Aditi Chatterjee
p 108-109
Research Perspectives
No limit to maximal lifespan in humans: how to beat a 122-year-old record
https://doi.org/10.18632/oncoscience.547
Mikhail V. Blagosklonny
p 110-119
Clinical Reports
Berry anthocyanidins inhibit intestinal polyps and colon tumors by modulation of Src, EGFR and the colon inflammatory environment
https://doi.org/10.18632/oncoscience.548
Ashley M. Mudd, Tao Gu, Radha Munagala, Jeyaprakash Jeyabalan, Mostafa Fraig, Nejat K. Egilmez, Ramesh C. Gupta
p 120-133
Abstract | PDF | Full Text | How to Cite
Clinical Reports
VTT-006, an anti-mitotic compound, binds to the Ndc80 complex and suppresses cancer cell growth in vitro
https://doi.org/10.18632/oncoscience.549
Leena J. Laine, Jenni H.E. Mäki-Jouppila, Emma Kutvonen, Pekka Tiikkainen, Thomas K.M. Nyholm, Jerry F. Tien, Neil T. Umbreit, Ville Härmä, Lila Kallio, Trisha N. Davis, Charles L. Asbury, Antti Poso, Gary J. Gorbsky, Marko J. Kallio
p 134-153
Abstract | PDF | Full Text | Supplementary Material | Supplementary Movie 1 | Supplementary Movie 2 | Supplementary Movie 3 | Supplementary Movie 4 | Supplementary Movie 5 | How to Cite